InvestorsHub Logo
icon url

rosemountbomber

06/01/23 7:37 AM

#409927 RE: couldbebetter #409926

OK.

Edding will pursue the Cardiovascular indication.



Do you mean apply for that indication like they did for this Marine? How long will that take?

Hey, everyone, I am not complaining, if we really can start selling even into the Marine indication in China that would be a good start. Just want to be clear that this is not for CVD.

Maybe the Chinese will keep the R-I indication for themselves - Ha!
icon url

ziploc_1

06/01/23 7:38 AM

#409928 RE: couldbebetter #409926

cbb...Since Vascepa has a long history of being safe and effective for reduction of CVD in Europe, in the U.S., in Canada, and in ROW, approval for Vascepa for CVD in China should not take as long as did the China approval for the high triglyceride indication.